I think we're going to come close to Canada at the end of the day,

[The issue has raised] many difficult and novel policy and regulatory issues, ... We need to resolve these policy and regulatory questions before we can reach a decision on the underlying science.

Previous shortages highlighted the need for additional influenza vaccine manufacturers for the U.S. market,

[How to enforce an age limit is the] key unresolved question, ... FDA cannot have an inspector in every pharmacy.

Previous shortages highlighted the need for additional influenza vaccine manufacturers for the U.S. market, ... Accelerated approval has allowed us to evaluate and approve Fluarix in record time so that we can make available additional safe and effective flu vaccines.

Each and every day I will assure you of one thing -- I will dedicate myself to making Canada more united, stronger, more prosperous and a safer country.